Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial

類似資料

• Rapid and early virological response to chronic hepatitis C treatment with IFN α2b or PEG‐IFN α2b plus ribavirin in HIV/HCV co‐infected patients
  著者:: Payan, Christopher, 等
  出版事項: (2007)
• The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone
  著者:: Lin, Sheng, 等
  出版事項: (2020)
• European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response
  著者:: Dimitroulopoulos, Dimitrios, 等
  出版事項: (2010)
• Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS®)
  著者:: Bressler, Brian, 等
  出版事項: (2009)
• Impaired HCV Clearance in HIV/HCV Coinfected Subjects Treated with PegIFN and RBV Due to Interference of IFN Signaling by IFNαR2a
  著者:: Lee, Yu-Jin, 等
  出版事項: (2014)